Role of the specific airway resistance (sRaw) in 4-6 years fibrosis cistic patients

E. Bucchioni, D. Costantini, A. Brivio, C. Colombo, L. Allegra (Milan, Italy)

Source: Annual Congress 2004 - Modern techniques bringing new insights into cystic fibrosis
Session: Modern techniques bringing new insights into cystic fibrosis
Session type: Thematic Poster Session
Number: 2400
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Bucchioni, D. Costantini, A. Brivio, C. Colombo, L. Allegra (Milan, Italy). Role of the specific airway resistance (sRaw) in 4-6 years fibrosis cistic patients. Eur Respir J 2004; 24: Suppl. 48, 2400

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Reporting specific airway resistance (sRaw) in children: mean or median?
Source: Annual Congress 2006 - Landmark developments in lung function testing: 2006
Year: 2006


Pseudomonas aeruginosa (Pa) antibiotic resistance (AR): Comparison in adults and children with cystic fibrosis (CF)
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010


Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020


Dual release ciprofloxacin for inhalation (DRCFI) reduces sputum pseudomonas aeruginosa (Pa) density and delays time to infective pulmonary exacerbation in non-cystic fibrosis (CF) bronchiectasis (BE)
Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis
Year: 2011


Evaluation of the pulmonary function of patients with cystic fibrosis aged 3-18 year old by using impulse oscillometry and spirometry
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015

Lung clearance index (LCI) and hyperinflation in children with cystic fibrosis (CF)
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012


Late Breaking Abstract - Reduction in frequency of pulmonary exacerbations (PE) with inhaled ARD-3150 in non-cystic fibrosis bronchiectasis (NCFB) patients is independent of Pseudomonas aeruginosa (PA) susceptibility at baseline
Source: International Congress 2017 – Update on community acquired pneumonia
Year: 2017



Arterial partial pressure of oxygen (PaO2) - a marker for cystic fibrosis (CF) lung disease and chronic airway infection
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019


ABPA syndrome (ABPAs) in CF: FEV1 decline, infectious exacerbations and BMI before and after the year of diagnosis (index year), a case control study
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Scond may better discriminate severe therapy resistant asthma (STRA) from mild-moderate asthma than lung clearance index (LCI)
Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease
Year: 2016


Breathing pattern during rest and exercise in patients with cystic fibrosis (CF), pulmonary fibrosis (PF) and COPD before lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 685s
Year: 2005

Comparison of ventilation heterogeneity (VH) measured with multiple breath washout (MBW) imaging to whole lung MBW LCI and FEV1 in asthma and cystic fibrosis (CF)
Source: International Congress 2015 – Functional imaging approaches for evaluating alteration of lung, airways and respiratory muscles
Year: 2015


Lung clearance index (LCI) at age 1-4 years vs lung function and chest X-ray (CXR) scores at age 7 years in children with CF
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011

Is lung function diminished by 3 months of age in infants with cystic fibrosis (CF) diagnosed by newborn screening (NBS)?
Source: Annual Congress 2010 - Functional assessment of paediatric lung disease
Year: 2010


Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients?
Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017

Relationship between nasal potential difference (NPD) and respiratory function in cystic fibrosis (CF) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 125s
Year: 2001

Lung function abnormalities in asthmatic children (a 3-5 year follow-up study)
Source: Eur Respir J 2001; 18: Suppl. 33, 120s
Year: 2001

Degree of bronchial hyperresponsiveness (BHR) and new onset of respiratory diseases 9 years later
Source: Annual Congress 2011 - Asthma mechanisms
Year: 2011

Variability of the lung clearance index (LCI) assessed pre and post physiotherapy in patients with cystic fibrosis (CF)
Source: Annual Congress 2008 - Clinical applications of ventilatory function tests in paediatric pulmonology
Year: 2008

Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013